Trial Profile
Novel Therapies for Metabolic Complications in Patients With Lipodystrophies.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Cholic acid; Leptin
- Indications Diabetes mellitus; Fatty liver; Hypertriglyceridaemia; Insulin resistance; Lipodystrophy
- Focus Therapeutic Use
- 11 Oct 2018 Status changed from recruiting to completed.
- 20 Jun 2013 Planned end date changed from 1 Aug 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 02 Aug 2011 Planned end date changed from 1 Aug 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov.